Real world experience of third line docetaxel ± nintedanib post-nivolumab for treatment of metastatic NSCLC in the West of Scotland
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI